A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.
The Scientist
Most Recent
Obama wants to invest in science and technology, but a divided Congress and looming budget cuts could make it difficult to keep his promises.
Nominated as a write-in candidate as a protest against the anti-science incumbent, famed naturalist Charles Darwin won 4,000 congressional votes in a Georgia county.
From education to space, science fared well at the polls on Tuesday.
Biotech, pharmaceutical, and insurance companies have spent a record-breaking amount this election—nearly $200 million.
A number of studies have linked genes and hormones to political attitudes and behaviors, though the evidence remains controversial.
In the wake of Hurricane Sandy, New York City Mayor Michael Bloomberg announces his support for President Barack Obama's reelection, citing concern over climate change.
New noninvasive methods of selecting the most viable embryo could revolutionize in vitro fertilization.
Contributors
| November 1, 2012
Meet some of the people featured in the November 2012 issue of The Scientist.
Large RNA-protein packets use a novel mechanism to escape the cell nucleus.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
